Eledon Pharmaceuticals, Inc. (ELDN) Tops Q1 EPS by 17c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.08), $0.17 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
• Deutsche Bank Upgrades Huizhou Desay Sv Automotive Co (002920:CH) to Hold